MedTrace Logo

The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms

NCT04927806 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-03-01

No results posted yet for this study

Summary

The aim of this study is to investigates the effectiveness of antimicrobial breathing system on multidrug-resistant organisms (MDRO).

Conditions

  • Bacterial Contamination

Interventions

DEVICE

Silver Knight

Silver Knight breathing systems are all validated for up to seven days use, and remain active, in unopened packaging, for up to five years. Silver Knight is proven to help reduce the incidence of MRSA infection and other organisms including: * Staphyloccus epidermis * Pseudomonas aeruginosa * Klebsiella pneumoniae * Acinetobacter calcoaceticus * Escherichia coli

Sponsors & Collaborators

  • Fu Jen Catholic University

    lead OTHER

Principal Investigators

  • Wen-Lun Liu, MD · Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-06-01
Completion
2022-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927806 on ClinicalTrials.gov